Skip to main content

Our approach

Collaborations are critical to our own success and the success of the industry.

Creating partnerships that make a difference

At AbbVie, we partner to achieve two important outcomes: to deliver innovative medicines and to make a remarkable impact on people’s lives.

We start with a highly integrated approach to developing and sustaining our partnerships. We work as one connected unit with a commitment to establishing collaborations across the development continuum that will ultimately benefit patients and fuel scientific progress.

Our goal is to create long-term mutually beneficial relationships. With a shared vision as our foundation, we align our collective capabilities in service of a joint mission to bring innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.

From start to finish, we ensure that everyone from working teams through senior leadership is aware of and invested in nurturing the assets we develop together. We manage for success—from early identification and mitigation of risks to shared accountability and reward for successful outcomes.

How we work together

Search and Evaluation

We focus on identifying and evaluating new opportunities that complement and enhance  our existing internal innovation strategies. S&E works in close partnership with our R&D  and commercial teams, BD&A and Ventures  to thoughtfully address each opportunity.

Business Development and Acquisitions

We evaluate a variety of partnership structures to meet the needs of both parties. BD&A works closely with S&E,  and our commercial and R&D organizations  to evaluate new opportunities.

Alliance Management to Global Alliances

Highly successful partnerships result from an ongoing commitment to realize a shared vision. At AbbVie, we have a dedicated team that is involved in all aspects of the partnership from contracting through commercialization.

AbbVie Ventures

We strategically invest in transformational scientific opportunities to augment our core R&D interests and gain access to next-generation science and proven scientific leaders. Our expertise in drug development and commercialization can be a valuable resource to even the earliest stage companies

The Partnerships Team

Our team is ready to meet with you to share our capabilities and discuss your business opportunities. We are always looking for innovation and new partnership opportunities that align with our focus areas. With offices in the Northern California, Chicago and Boston areas, as well as other locations around the world, we look forward to hearing from you.

Contact us to submit your idea.

Search & Evaluation

Niels Emmerich, Vice President, Global Head Search & Evaluation
Debra Chao, Senior Director, Oncology
Murali Gopalakrishnan, Senior Director, Neuroscience
Liz Kowaluk, Senior Director, Specialty
Arpita Maiti, Senior Director, Immunology
Douglas Faunce, Executive Director, Eye Care
Chinmay Kanuga, Director, Allergan Aesthetics
Joachim Vogt, Director, Western Europe
Sergio Capancioni, Director, Western Europe
Wendy Tai, Director, Japan/Asia/Pacific

Business Development & Acquisitions

Jay Stamatis, Vice President, Head Business Development & Acquisitions
Rahul Jerath, Senior Director, Oncology
Tony Brazda, Senior Director, Allergan Aesthetics
Rachel Strick, Senior Director, Immunology
David Moss, Associate VP, Eye Care, Neuropsych, Migraine
John FitzGerald, Senior Director, Outlicensing, Specialty
Sridhar Mandapati, Head International Business Development

Global Alliances

Anna Maroney, Vice President, Global Alliances
John Larson, Senior Director Global Alliance Leader, Oncology, Marketed Drugs
Jason Powell, Senior Director Global Alliance Leader, Oncology, Immunology
Jon Kern, Senior Director Global Alliance Leader, Allergan Aesthetics, Immunology
Shankar Subramanian, Senior Director Global Alliance Leader, Academic Collaborations
Melanie Patterson, Director Global Alliance Leader, Neuroscience, Oncology
Amanda McAllister, Director Global Alliance Leader, Specialty, Immunology, Oncology 
Ching-Yi Wan, Associate Director Global Alliance Leader, Oncology
Rajiv Janjikhel, Executive Director Global Alliance Leader, Eye Care, Neuroscience
Cardine Nokwe, Director Global Alliance Leader, Specialty, Immunology

AbbVie Ventures

Margarita Chavez, Chicago / San Francisco area
John Gustofson, Boston / Cambridge area
Charles Kunsch, Ph.D., Boston / Cambridge area
Jasmina Marjanovic, Ph.D., Boston / Cambridge area
Danjuma Quarless, Ph.D., San Francisco area